Certara, Inc. (CERT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Certara, Inc. (CERT)
Company Performance

Current Price

as of Dec 03, 2024

$11.26

P/E Ratio

N/A

Market Cap

$1.81B

Description

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Metrics

Overview

  • HQRadnor, PA
  • SectorTechnology Services
  • IndustryPackaged Software
  • TickerCERT
  • Price$11.26-0.27%

Trading Information

  • Market cap$1.81B
  • Float69.15%
  • Average Daily Volume (1m)1,245,844
  • Average Daily Volume (3m)1,318,829
  • EPS-$0.19

Company

  • Revenue$372.80M
  • Rev growth (1yr)10.80%
  • Net income-$1.37M
  • Gross margin46.66%
  • EBITDA margin26.14%
  • EBITDA$24.78M
  • EV$1.96B
  • EV/Revenue5.26
  • P/EN/A
  • P/S4.85
  • P/B1.72
Documents